Lantheus Holdings Current Ratio 2013-2019 | LNTH
Lantheus Holdings current ratio from 2013 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Lantheus Holdings Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2019-03-31 | $0.20B | $0.04B | 4.57 |
| 2018-12-31 | $0.20B | $0.05B | 3.70 |
| 2018-09-30 | $0.19B | $0.06B | 3.50 |
| 2018-06-30 | $0.17B | $0.04B | 3.86 |
| 2018-03-31 | $0.16B | $0.05B | 3.51 |
| 2017-12-31 | $0.15B | $0.05B | 3.16 |
| 2017-09-30 | $0.14B | $0.05B | 2.96 |
| 2017-06-30 | $0.13B | $0.04B | 2.92 |
| 2017-03-31 | $0.11B | $0.04B | 2.73 |
| 2016-12-31 | $0.11B | $0.04B | 2.53 |
| 2016-09-30 | $0.11B | $0.04B | 2.82 |
| 2016-06-30 | $0.11B | $0.03B | 3.32 |
| 2016-03-31 | $0.10B | $0.03B | 3.18 |
| 2015-12-31 | $0.09B | $0.04B | 2.53 |
| 2015-09-30 | $0.08B | $0.03B | 2.43 |
| 2015-06-30 | $0.08B | $0.04B | 2.10 |
| 2015-03-31 | $0.00B | $0.00B | 0.00 |
| 2014-12-31 | $0.00B | $0.00B | 0.00 |
| 2014-09-30 | $0.00B | $0.00B | 0.00 |
| 2014-06-30 | $0.00B | $0.00B | 0.00 |
| 2013-12-31 | $0.08B | $0.06B | 1.42 |
| 2012-12-31 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.941B | $0.343B |
| Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations, radiopharmacies and wholesalers. Lantheus Holdings, Inc. is based in NORTH BILLERICA, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $134.025B | 26.02 |
| Medtronic (MDT) | Ireland | $117.659B | 17.20 |
| Stryker (SYK) | United States | $68.704B | 24.52 |
| Boston Scientific (BSX) | United States | $51.899B | 24.88 |
| Baxter (BAX) | United States | $38.763B | 24.43 |
| Zimmer Biomet Holdings (ZBH) | United States | $23.843B | 15.32 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $18.247B | 0.00 |
| ResMed (RMD) | United States | $16.172B | 30.90 |
| Canopy Growth (CGC) | Canada | $15.352B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.842B | 46.88 |
| Aurora Cannabis (ACB) | Canada | $8.802B | 86.80 |
| Perrigo (PRGO) | Ireland | $6.755B | 11.42 |
| Hill-Rom Holdings (HRC) | United States | $6.504B | 19.72 |
| Insulet (PODD) | United States | $6.200B | 451.74 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $5.280B | 0.00 |
| Haemonetics (HAE) | United States | $5.104B | 41.87 |
| ICU Medical (ICUI) | United States | $4.630B | 27.62 |
| Hutchison China MediTech (HCM) | China | $3.565B | 0.00 |
| NuVasive (NUVA) | United States | $3.164B | 25.84 |
| Neogen (NEOG) | United States | $3.071B | 49.94 |
| Agios Pharmaceuticals (AGIO) | United States | $2.941B | 0.00 |
| Quidel (QDEL) | United States | $2.233B | 23.17 |
| National Vision Holdings (EYE) | United States | $2.120B | 45.18 |
| Aphria (APHA) | $1.712B | 0.00 | |
| Cardiovascular Systems (CSII) | United States | $1.377B | 790.80 |
| Phibro Animal Health (PAHC) | United States | $1.168B | 17.50 |
| AtriCure (ATRC) | United States | $1.136B | 0.00 |
| VAREX IMAGING (VREX) | United States | $1.083B | 22.98 |
| NanoString Technologies (NSTG) | United States | $0.941B | 0.00 |
| Omeros (OMER) | United States | $0.914B | 0.00 |
| MacroGenics (MGNX) | United States | $0.913B | 0.00 |
| PetIQ (PETQ) | United States | $0.806B | 19.58 |
| Cerus (CERS) | United States | $0.754B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.753B | 21.11 |
| TG Therapeutics (TGTX) | United States | $0.609B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.541B | 26.20 |
| OraSure Technologies (OSUR) | United States | $0.529B | 24.37 |
| Surmodics (SRDX) | United States | $0.527B | 76.59 |
| Quanterix (QTRX) | United States | $0.498B | 0.00 |
| Meridian Bioscience (VIVO) | United States | $0.462B | 14.13 |
| Evolus (EOLS) | United States | $0.440B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.343B | 107.18 |
| Utah Medical Products (UTMD) | United States | $0.311B | 21.52 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.310B | 0.00 |
| Vapotherm (VAPO) | United States | $0.282B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.267B | 0.00 |
| Zynex (ZYXI) | United States | $0.240B | 24.80 |
| Owens & Minor (OMI) | United States | $0.226B | 4.79 |
| Cytosorbents (CTSO) | United States | $0.223B | 0.00 |
| Bovie Medical (APYX) | United States | $0.204B | 0.00 |
| Chimerix (CMRX) | United States | $0.179B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.134B | 0.00 |
| Fonar (FONR) | United States | $0.134B | 7.05 |
| Surface Oncology (SURF) | United States | $0.111B | 0.00 |
| Female Health (VERU) | United States | $0.103B | 0.00 |
| United-Guardian (UG) | United States | $0.094B | 20.70 |
| Neurotrope (NTRP) | United States | $0.091B | 0.00 |
| Insys Therapeutics (INSY) | United States | $0.079B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.058B | 20.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.053B | 0.00 |
| ImmuCell (ICCC) | United States | $0.045B | 0.00 |
| Senestech (SNES) | United States | $0.042B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.032B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.029B | 0.00 |
| BRAINSWAY LTD (BWAY) | Israel | $0.027B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.025B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.011B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.006B | 4.60 |
